FULC · Fulcrum Therapeutics, Inc. · Executive Compensation
$3.68
-0.02 (-0.54%)
At close · Oct 1
Return incl. dividend (before tax)
Market Cap
$285.35M
Shares
76.30M
Volume · Oct 1
1.23M
Avg daily vol (3M)
1.6M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Alex C. Sapir | President and Chief Executive Officer | $3,251,490 |
| Alan Musso | Chief Financial Officer | $1,807,125 |
| Curtis Oltmans | Chief Legal Officer and Head of External Affairs | $1,482,850 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Patrick Horn | Former Chief Medical Officer | $3,730,273 |
| Curtis Oltmans | Chief Legal Officer | $1,425,240 |
| Alan Musso | Chief Financial Officer | $1,251,760 |
| Alex C. Sapir | President and Chief Executive Officer | $1,003,300 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Alex C. Sapir | President and Chief Executive Officer | $6,990,596 |
| Curtis Oltmans | Chief Legal Officer | $2,319,661 |
| Mel Hayes | Executive Vice President, Patient Affairs | $2,192,854 |
| Alan Musso | Chief Financial Officer | $1,879,833 |
| Bryan Stuart | Former President and Chief Executive Officer | $1,869,696 |
| Robert J. Gould | Former Interim President and Chief Executive Officer | $424,501 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Bryan Stuart | Former President and Chief Executive Officer | $3,971,756 |
| Esther Rajavelu | Former Chief Financial Officer | $3,349,680 |
| Santiago Arroyo | Former Chief Medical Officer | $1,875,318 |
| Robert J. Gould | Former Interim President and Chief Executive Officer | $118,342 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Bryan Stuart | Former President and Chief Executive Officer | $5,055,104 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Robert J. Gould | President and Chief Executive Officer | $3,016,350 |
| Bryan Stuart | Chief Operating Officer | $1,774,715 |
| Curtis Oltmans | — | $1,357,367 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Robert J. Gould | President and Chief Executive Officer | $3,889,353 |
| Owen Wallace | Chief Scientific Officer | $1,559,523 |
| Bryan Stuart | Chief Operating Officer | $1,234,960 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Robert J. Gould | President and Chief Executive Officer Bryan Stuart .^ | $853,634 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Alan Musso | principal accounting officer | Appointed | 2026-08-10 |
| Josh Lehrer | member of the Board | Appointed | 2026-04-27 |
| Rachel King | member of the Board | Appointed | 2024-11-12 |
| James J. Collins | Class II director | Resigned | 2024-11-12 |
| Colin Hill | Class I director | Appointed | 2024-06-17 |
| Mel Hayes | chief operating officer (and principal operating officer) | Terminated | 2023-10-02 |
| Alan A. Musso | principal financial officer | Appointed | 2023-08-03 |
| Alan A. Musso | chief financial officer and treasurer | Appointed | 2023-08-03 |
| Esther Rajavelu | chief financial officer | Resigned | 2023-05-15 |
| Alex C. Sapir | president and chief executive officer | Appointed | 2023-05-15 |
| Alex C. Sapir | class II director | Appointed | 2023-05-15 |
| Robert E. Gould | principal financial officer | Appointed | 2023-05-15 |
| Esther Rajavelu | chief financial officer and treasurer (and as principal financial officer) | Resigned | 2023-04-05 |
| Robert J. Gould | interim president and chief executive officer | Appointed | 2023-01-04 |
| Judith A. Dunn | president, research and development | Resigned | 2022-10-19 |
| Mel Hayes | chief operating officer | Appointed | 2022-08-11 |